NEXGEL, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -28.28%

NEXGEL, Inc. EBITDA Margin is -28.28% for the Trailing 12 Months (TTM) ending March 31, 2025, a -54.52% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • NEXGEL, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -62.18%, a -49.88% change year over year.
  • NEXGEL, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -124.07%, a -25.22% change year over year.
  • NEXGEL, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -165.91%, a -46.89% change year over year.
  • NEXGEL, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -312.41%, a 45.73% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin